ClinConnect ClinConnect Logo
Search / Trial NCT04559919

Prospective Regional Epilepsy Database

Launched by SAHLGRENSKA UNIVERSITY HOSPITAL · Sep 16, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Epilepsy Biomarker Access To Care Quality Of Care Seizure

ClinConnect Summary

The Prospective Regional Epilepsy Database (PREDICT) is a study designed to learn more about epilepsy, a condition that causes seizures. Researchers in western Sweden are following adults who have experienced an unprovoked seizure (a seizure that happens without any clear cause) or have been diagnosed with epilepsy. The goal is to find out more about the genetic factors and other markers that could help with the diagnosis and treatment of epilepsy, as well as to understand the long-term effects of living with this condition.

To participate in this study, individuals need to be over 18 years old and have had an unprovoked seizure in the last year or a diagnosis of epilepsy within certain guidelines. Unfortunately, people who are expected to live for less than two more years or cannot provide informed consent (which means they can’t fully understand the study details) are not eligible. Participants will have the chance to contribute to important research that could help improve future treatments for epilepsy, and they will be closely monitored by healthcare professionals throughout the study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Over 18 years of age
  • An unprovoked seizure within the last year or a diagnosis of epilepsy according to the current International League Against Epilepsy definition (epilepsy with seizure in the last ten or antiepileptic drug treatment in the last five years)
  • Exclusion Criteria:
  • Expected survival less than two years
  • Inability to give informed consent

About Sahlgrenska University Hospital

Sahlgrenska University Hospital, a leading healthcare institution in Sweden, is at the forefront of clinical research and innovation. Affiliated with the University of Gothenburg, the hospital integrates advanced medical care with cutting-edge research, facilitating a collaborative environment for scientific exploration and clinical trials. With a commitment to improving patient outcomes, Sahlgrenska University Hospital focuses on a wide range of therapeutic areas, leveraging its multidisciplinary expertise to advance healthcare solutions. The institution is dedicated to fostering ethical research practices and ensuring the highest standards of patient safety and care in all clinical trials.

Locations

Gothenburg, , Sweden

Borås, , Sweden

Gothenburg, , Sweden

Patients applied

0 patients applied

Trial Officials

Johan Zelano, MD PhD

Principal Investigator

Sahlgrenska University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials